von Mässenhausen, A.* ; Zamora Gonzalez, N.* ; Maremonti, F.* ; Belavgeni, A.* ; Tonnus, W.* ; Meyer, C.* ; Beer, K.* ; Hannani, M.T.* ; Lau, A.* ; Peitzsch, M.* ; Hoppenz, P.* ; Locke, S.* ; Chavakis, T.* ; Kramann, R.* ; Muruve, D.A.* ; Hugo, C.* ; Bornstein, S.R. ; Linkermann, A.*
     
    
        
Dexamethasone sensitizes to ferroptosis by glucocorticoid receptor-induced dipeptidase-1 expression and glutathione depletion.
    
    
        
    
    
        
        Sci. Adv. 8:eabl8920 (2022)
    
    
    
      
      
	
	    Dexamethasone is widely used as an immunosuppressive therapy and recently as COVID-19 treatment. Here, we demonstrate that dexamethasone sensitizes to ferroptosis, a form of iron-catalyzed necrosis, previously suggested to contribute to diseases such as acute kidney injury, myocardial infarction, and stroke, all of which are triggered by glutathione (GSH) depletion. GSH levels were significantly decreased by dexamethasone. Mechanistically, we identified that dexamethasone up-regulated the GSH metabolism regulating protein dipeptidase-1 (DPEP1) in a glucocorticoid receptor (GR)-dependent manner. DPEP1 knockdown reversed the phenotype of dexamethasone-induced ferroptosis sensitization. Ferroptosis inhibitors, the DPEP1 inhibitor cilastatin, or genetic DPEP1 inactivation reversed the dexamethasone-induced increase in tubular necrosis in freshly isolated renal tubules. Our data indicate that dexamethasone sensitizes to ferroptosis by a GR-mediated increase in DPEP1 expression and GSH depletion. Together, we identified a previously unknown mechanism of glucocorticoid-mediated sensitization to ferroptosis bearing clinical and therapeutic implications.
	
	
	    
	
       
      
	
	    
		Impact Factor
		Scopus SNIP
		Web of Science
Times Cited
		Scopus
Cited By
		Altmetric
		
	     
	    
	 
       
      
     
    
        Publication type
        Article: Journal article
    
 
    
        Document type
        Scientific Article
    
 
    
        Thesis type
        
    
 
    
        Editors
        
    
    
        Keywords
        Site-directed Mutagenesis; Renal Dipeptidase; Heme Oxygenase-1; Cell-death; Kidney; Degradation; Induction; Residues; Protects; Features
    
 
    
        Keywords plus
        
    
 
    
    
        Language
        english
    
 
    
        Publication Year
        2022
    
 
    
        Prepublished in Year
        
    
 
    
        HGF-reported in Year
        2022
    
 
    
    
        ISSN (print) / ISBN
        2375-2548
    
 
    
        e-ISSN
        2375-2548
    
 
    
        ISBN
        
    
    
        Book Volume Title
        
    
 
    
        Conference Title
        
    
 
	
        Conference Date
        
    
     
	
        Conference Location
        
    
 
	
        Proceedings Title
        
    
 
     
	
    
        Quellenangaben
        
	    Volume: 8,  
	    Issue: 5,  
	    Pages: ,  
	    Article Number: eabl8920 
	    Supplement: ,  
	
    
 
    
        
            Series
            
        
 
        
            Publisher
            American Association for the Advancement of Science (AAAS)
        
 
        
            Publishing Place
            Washington, DC [u.a.]
        
 
	
        
            Day of Oral Examination
            0000-00-00
        
 
        
            Advisor
            
        
 
        
            Referee
            
        
 
        
            Examiner
            
        
 
        
            Topic
            
        
 
	
        
            University
            
        
 
        
            University place
            
        
 
        
            Faculty
            
        
 
    
        
            Publication date
            0000-00-00
        
 
         
        
            Application date
            0000-00-00
        
 
        
            Patent owner
            
        
 
        
            Further owners
            
        
 
        
            Application country
            
        
 
        
            Patent priority
            
        
 
    
        Reviewing status
        Peer reviewed
    
 
    
        Institute(s)
        Institute of Pancreatic Islet Research (IPI)
    
 
    
        POF-Topic(s)
        90000 - German Center for Diabetes Research
    
 
    
        Research field(s)
        Helmholtz Diabetes Center
    
 
    
        PSP Element(s)
        G-502600-007
    
 
    
        Grants
        Technische Universität Dresden
Sander-Stiftung
Else Kroner-Fresenius Stiftung
State of Saxony
Deutsche Forschungsgemeinschaft
European Fund for Regional Development-EFRE
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2022-04-29